Primer: Legochem Biosciences (141080 KS) - Aug 2026
Legochem Biosciences is a clinical-stage biotechnology company specializing in the development of Antibody-Drug Conjugates (ADCs) for oncology,...
90 Views
APAC Healthcare Weekly (August 30)– CSPC Pharma, Akeso, Takeda, Astellas, Hanmi Pharm, SK Biopharma
CSPC and Akeso announced positive results from their respective Phase 3 trials for cancer drug candidates. Takeda got FDA approval for blood cancer...
103 Views
LigaChem Biosciences (141080 KQ/Buy)Clinical Data to Watch in 2026
We valued LCB14 (HER2-targeting ADC; regulatory filing in China expected in 2026) at W1.47tr and LCB84 (Trop2-targeting ADC; phase 1 trials to be...
379 Views
APAC Healthcare Weekly (August 2) – CSPC, Hengrui, Otsuka, Nippon Shinyaku, PharmaEssnetia, Cipla
Hengrui got NMPA approval for long-acting insulin. FDA approves Otsuka’s new CNS drug. Pharmaessentia announced positive topline result from Phase...
136 Views
APAC Healthcare Weekly (June 28) – Insilico, Abbisko, Nippon Shinyaku, Otsuka, Yuhan Corp, Medytox
Few Chinese companies signed outlicensing deals. Nippon Shinyaku’s partner Regenxbio will resubmit gene therapy drug candidate to FDA. Otsuka...
144 Views